Prevention of Atrial Fibrillation by Using Sarcoplasmic Reticulum Calcium ATPase Pump Overexpression in a Rabbit Model of Rapid Atrial Pacing

BACKGROUND: Recent research suggests that abnormal Ca(2+) handling plays a role in the occurrence and maintenance of atrial fibrillation (AF). Therefore, Ca(2+) release and ingestion depend on properties of the ryanodine receptor (RyR) and sarcoplasmic reticulum Ca(2+)ATPase2a (SERCA2a). This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hong li, Zhou, Xian hui, Li, Zhi qiang, Fan, Ping, Zhou, Qi na, Li, Yao dong, Hou, Yue mei, Tang, Bao peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Animal Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569926/
https://www.ncbi.nlm.nih.gov/pubmed/28811460
http://dx.doi.org/10.12659/MSM.904824
Descripción
Sumario:BACKGROUND: Recent research suggests that abnormal Ca(2+) handling plays a role in the occurrence and maintenance of atrial fibrillation (AF). Therefore, Ca(2+) release and ingestion depend on properties of the ryanodine receptor (RyR) and sarcoplasmic reticulum Ca(2+)ATPase2a (SERCA2a). This study aimed to detect whether SERCA2a gene overexpression has a preventive effect on atrial fibrillation caused by rapid pacing right atrium. MATERIAL/METHODS: Forty-eight New Zealand white rabbits were randomly divided into a control group, AF group, AAV9/GFP group, and AAV9/SERCA2a group. The right atrium was rapidly paced at 600 beats/min for 30 days after an intraperitoneal injection of an adeno-associated virus expressing the SERCA2a gene and GFP. The AF induction rate and the effective refraction period (ERP) were measured after 0, 4, 8, 12, and 24 h of pacing. Western blot analysis was used to test for the expression of SERCA2a. Changes in atrial tissue structure were observed by H&E staining and electron microscopy. RESULTS: The AF induction rate was higher in the AF groups than in the AAV9/SERCA2a group at different time points of pacing. After 12 h of pacing, ERP was significantly prolonged in the AAV9/SERCA2a group compared to the AF and AAV9/GFP groups (p<0.05). SERCA2a protein expression was significantly lower in the AF and AAV9/GFP groups compared to the control group (p<0.05), while expression was significantly higher in the AAV9/SERCA2a group than in the AF and AAV9/GFP groups (p<0.05). The myocardial structure of the AAV9/SERCA2a group was significantly improved compared with the AF group, indicating that SERCA2a overexpression relieved the structural remodeling of atrial fibrillation. CONCLUSIONS: SERCA2a overexpression is capable of suppressing ERP shortening and AF induced by rapid pacing atrium. SERCA2a gene therapy is expected to be a new anti-atrial fibrillation strategy.

Ejemplares similares